Rocket Lab’s (RKLB) Buy Rating Reiterated at TD Cowen
by Michael Walen · The Markets DailyTD Cowen reissued their buy rating on shares of Rocket Lab (NASDAQ:RKLB – Free Report) in a research report report published on Thursday,Benzinga reports. They currently have a $90.00 price target on the rocket manufacturer’s stock.
RKLB has been the topic of several other research reports. Morgan Stanley restated an “overweight” rating on shares of Rocket Lab in a report on Wednesday, July 8th. Berenberg Bank started coverage on shares of Rocket Lab in a report on Wednesday, September 2nd. They issued a “buy” rating and a $83.00 price objective on the stock. Wall Street Zen cut Rocket Lab from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Barclays started coverage on shares of Rocket Lab in a research report on Friday, October 9th. They set an “overweight” rating and a $85.00 price target on the stock. Finally, KGI Securities upgraded Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 price objective for the company in a research report on Monday, July 27th. Three research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $102.05.
Check Out Our Latest Report on RKLB
Rocket Lab Stock Down 8.0%
Shares of RKLB opened at $50.84 on Thursday. The company has a market capitalization of $30.42 billion, a P/E ratio of -188.29 and a beta of 2.93. Rocket Lab has a one year low of $37.57 and a one year high of $151.00. The business’s 50 day simple moving average is $68.86 and its 200-day simple moving average is $84.06. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98.
Rocket Lab (NASDAQ:RKLB – Get Free Report) last released its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The business had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. As a group, sell-side analysts predict that Rocket Lab will post -0.20 EPS for the current fiscal year.
Insider Activity at Rocket Lab
In other Rocket Lab news, CAO Agostino Ricupati sold 669 shares of Rocket Lab stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $46,582.47. Following the completion of the transaction, the chief accounting officer directly owned 26,863 shares of the company’s stock, valued at $1,870,470.69. The trade was a 2.43% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Adam Spice sold 140,157 shares of the business’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $70.82, for a total transaction of $9,925,918.74. Following the completion of the transaction, the chief financial officer owned 1,155,967 shares of the company’s stock, valued at $81,865,582.94. The trade was a 10.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 400,749 shares of company stock valued at $26,964,474. 8.40% of the stock is currently owned by company insiders.
Institutional Trading of Rocket Lab
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Signature Resources Capital Management LLC purchased a new position in Rocket Lab in the third quarter worth $53,000. SteelPeak Wealth LLC grew its position in shares of Rocket Lab by 53.7% during the 3rd quarter. SteelPeak Wealth LLC now owns 6,511 shares of the rocket manufacturer’s stock valued at $454,000 after purchasing an additional 2,275 shares in the last quarter. Eagle Strategies LLC increased its stake in Rocket Lab by 40.7% in the 3rd quarter. Eagle Strategies LLC now owns 9,404 shares of the rocket manufacturer’s stock worth $655,000 after acquiring an additional 2,721 shares during the last quarter. TB Alternative Assets Ltd. raised its stake in Rocket Lab by 508.5% in the third quarter. TB Alternative Assets Ltd. now owns 320,703 shares of the rocket manufacturer’s stock valued at $22,347,000 after purchasing an additional 268,000 shares in the last quarter. Finally, Cornerstone Enterprises LLC lifted its holdings in shares of Rocket Lab by 74.4% during the 3rd quarter. Cornerstone Enterprises LLC now owns 6,122 shares of the rocket manufacturer’s stock worth $427,000 after acquiring an additional 2,611 shares during the last quarter. Institutional investors own 71.78% of the company’s stock.
Rocket Lab News Summary
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Rocket Lab continues to benefit from strong existing operations, including its Electron launch business, satellite systems activities and defense contracts. The company reported record second-quarter revenue of approximately $234 million, up 62% year over year, and maintains a backlog of roughly $2.36 billion. Rocket Lab Still Has a $2.4B Backlog While Neutron Waits
- Positive Sentiment: Despite reducing estimates, several analysts remain bullish. Citizens JMP lowered its target to $90 from $130 but retained a Market Outperform rating; TD Cowen maintained a Buy rating and $90 target, while Cantor Fitzgerald and Roth Capital also remained constructive. Rocket Lab analyst coverage
- Neutral Sentiment: Management said the manufacturing issue has been addressed and that additional testing is expected before a launch date is finalized. The company is prioritizing reliability and quality, but investors must now wait longer for evidence that Neutron can expand Rocket Lab into the larger medium-lift launch market. Rocket Lab discusses Neutron program update and manufacturing challenges
- Negative Sentiment: The delay is especially damaging because Neutron is central to Rocket Lab’s growth and planned path toward adjusted EBITDA profitability. Repeated schedule slips are increasing execution concerns, extending cash-burn risk and postponing potential launch revenue. Rocket Lab pushes Neutron rocket debut flight to 2027
- Negative Sentiment: Technical momentum has also weakened after the sell-off pushed RKLB below the closely watched $60 support level and below its major moving averages. Although Wall Street’s consensus remains broadly positive, lower price targets and renewed skepticism have added pressure to the stock.
About Rocket Lab
Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.
Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.
See Also
- Five stocks we like better than Rocket Lab
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery